| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ORKA
Oruka Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
+61.8% avg upside
16 analysts
|
— | +28.3% |
|
LLY
Eli Lilly & Co
|
Jun 02, 2026 | BUY |
Strong Buy
-10.5% avg upside
47 analysts
|
— | +3.2% |
|
ANAB
AnaptysBio
|
May 27, 2026 | BUY |
Strong Buy
+26.1% avg upside
26 analysts
|
— | -0.1% |
|
REGN
Regeneron
|
May 18, 2026 | HOLD |
Strong Buy
+26.9% avg upside
57 analysts
|
$641.00
5.01% Upside
|
-3.3% |
|
JNJ
Johnson & Johnson
|
May 15, 2026 | BUY |
Strong Buy
-3.6% avg upside
36 analysts
|
$265.00
15.97% Upside
|
+4.3% |
|
IMA
ImageneBio
|
May 08, 2026 | BUY |
Strong Buy
+179.6% avg upside
12 analysts
|
$24.00
300.07% Upside
|
+7.4% |
|
TRAX
First Tracks Biotherapeutics Inc
|
Apr 24, 2026 | BUY |
Strong Buy
+113.2% avg upside
7 analysts
|
$46.00
164.12% Upside
|
· |
|
CNTA
Centessa Pharmaceuticals
|
Apr 01, 2026 | HOLD |
Buy
-14.4% avg upside
19 analysts
|
$40.00
0.11% Downside
|
-0.0% |
|
XOMA
XOMA Royalty Corporation
|
Feb 24, 2026 | BUY |
Buy
-46.4% avg upside
11 analysts
|
$50.00
19.32% Upside
|
+54.2% |
|
BMY
Bristol-Myers Squibb
|
Jan 13, 2026 | BUY |
Buy
+9.1% avg upside
42 analysts
|
$60.00
11.13% Upside
|
-0.1% |
|
ABBV
AbbVie
|
Jan 13, 2026 | BUY |
Buy
+2.8% avg upside
43 analysts
|
— | +1.9% |
|
AMGN
Amgen
|
Jan 13, 2026 | HOLD |
Buy
-11.6% avg upside
57 analysts
|
— | +8.8% |
|
HALO
Halozyme
|
Jan 08, 2026 | HOLD |
Strong Buy
-13.7% avg upside
20 analysts
|
— | -4.9% |
|
VRTX
Vertex Pharmaceuticals
|
Dec 29, 2025 | BUY |
Strong Buy
-2.7% avg upside
61 analysts
|
$525.00
16.22% Upside
|
-0.2% |
|
FR:SAN
Sanofi
|
Dec 24, 2025 | BUY |
Strong Buy
+33.0% avg upside
30 analysts
|
— | · |
|
ROIV
Roivant Sciences
|
Dec 15, 2025 | BUY |
Strong Buy
+2.5% avg upside
17 analysts
|
$32.00
1.72% Upside
|
+42.5% |
|
PFE
Pfizer
|
Dec 09, 2025 | HOLD |
Buy
+34.1% avg upside
45 analysts
|
$26.00
3.10% Upside
|
+2.9% |
|
PCVX
Vaxcyte
|
Oct 01, 2025 | BUY |
Strong Buy
+96.3% avg upside
15 analysts
|
— | +29.5% |
|
TENX
Tenax Therapeutics
|
Sep 17, 2025 | BUY |
Strong Buy
+213.9% avg upside
8 analysts
|
— | +97.8% |
|
SNY
Sanofi
|
Sep 04, 2025 | BUY |
Strong Buy
+74.9% avg upside
20 analysts
|
— | +3.0% |
|
TECX
Tectonic Therapeutic
|
Sep 01, 2025 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
— | +67.5% |
|
SVRN
OceanPal Inc
|
Aug 17, 2025 | BUY |
Strong Buy
6 analysts
|
— | · |
|
TBPH
Theravance Biopharma
|
Aug 13, 2025 | HOLD |
Buy
+12.2% avg upside
18 analysts
|
$13.00
21.51% Downside
|
+34.5% |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
Aug 07, 2025 | BUY |
Strong Buy
+132.5% avg upside
17 analysts
|
$44.00
1.21% Downside
|
+125.8% |
|
MRNA
Moderna
|
Apr 16, 2025 | SELL |
Hold
+6.4% avg upside
38 analysts
|
$23.00
63.99% Downside
|
-117.1% |
|
MP
MP Materials
|
Feb 24, 2025 | BUY |
Strong Buy
+10.6% avg upside
21 analysts
|
$28.00
53.98% Downside
|
+140.8% |
|
IRWD
Ironwood Pharma
|
Jan 17, 2025 | HOLD |
Hold
+235.8% avg upside
23 analysts
|
— | +22.9% |
|
CABO
Cable ONE
|
May 01, 2024 | BUY |
Hold
+1189.4% avg upside
9 analysts
|
— | -31.7% |
|
GILD
Gilead Sciences
|
Apr 28, 2023 | HOLD |
Strong Buy
-4.8% avg upside
66 analysts
|
$91.00
26.41% Downside
|
-17.3% |
|
PAX
Patria Investments
|
Mar 14, 2023 | BUY |
Buy
+39.0% avg upside
7 analysts
|
— | +6.1% |
|
OGN
Organon
|
Jun 11, 2021 | HOLD |
Sell
+10.6% avg upside
9 analysts
|
$33.00
145.74% Upside
|
+23.6% |
|
JAZZ
Jazz Pharmaceuticals
|
May 21, 2021 | HOLD |
Strong Buy
-1.8% avg upside
35 analysts
|
$176.00
21.62% Downside
|
-17.5% |
|
PAHC
Phibro Animal Health
|
May 13, 2021 | SELL |
Hold
+17.0% avg upside
10 analysts
|
$22.00
30.85% Downside
|
+31.4% |
|
MRK
Merck & Company
|
Apr 01, 2021 | BUY |
Strong Buy
+10.7% avg upside
43 analysts
|
$90.00
20.96% Downside
|
+17.7% |
|
VTRS
Viatris
|
Mar 10, 2021 | HOLD |
Buy
+48.2% avg upside
21 analysts
|
$16.00
4.20% Upside
|
-25.7% |
|
PRGO
Perrigo Company
|
Mar 05, 2021 | HOLD |
Buy
+565.5% avg upside
20 analysts
|
$45.00
339.10% Upside
|
-8.8% |
|
TSE:BHC
Bausch Health Companies
|
Feb 26, 2021 | HOLD |
Buy
+783.6% avg upside
29 analysts
|
$49.34
632.00% Upside
|
· |
|
TEVA
Teva Pharmaceutical
|
Dec 21, 2020 | SELL |
Buy
-6.8% avg upside
39 analysts
|
$9.00
71.40% Downside
|
+14.9% |
|
ALKS
Alkermes
|
Dec 21, 2020 | HOLD |
Strong Buy
-17.5% avg upside
34 analysts
|
$22.00
51.05% Downside
|
+8.1% |
|
ELAN
Elanco Animal Health
|
Nov 23, 2020 | BUY |
Strong Buy
+24.1% avg upside
18 analysts
|
$41.00
69.37% Upside
|
+3.4% |
|
ZTS
Zoetis
|
Nov 13, 2020 | HOLD |
Buy
+71.4% avg upside
22 analysts
|
$174.00
121.14% Upside
|
+31.5% |
|
RPRX
Royalty Pharma
|
Jul 13, 2020 | HOLD |
Strong Buy
+4.2% avg upside
15 analysts
|
$51.00
3.66% Downside
|
-3.7% |
|
AMRX
Amneal Pharmaceuticals
|
Apr 02, 2020 | HOLD |
Strong Buy
+5.6% avg upside
18 analysts
|
$3.00
81.54% Downside
|
+116.4% |
|
COR
Cencora
|
Nov 16, 2015 | HOLD |
Buy
+14.6% avg upside
43 analysts
|
— | -17.9% |
|
ORCL
Oracle
|
Sep 21, 2012 | BUY |
Strong Buy
+19.0% avg upside
70 analysts
|
$36.00
80.49% Downside
|
+6.0% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.